Yasuo Takeuchi Director, Vice President and CFO PLAY LIST from the beginning Consolidated Financial Results for the 1st Quarter of Fiscal 2018 and Full-Year Forecasts Disclaimer Voluntary Adoption of IFRS Highlights Consolidated Financial Results and Business Overview for the 1Q of Fiscal 2018 (FY Ending March 31, 2018) 1Q of Fiscal 2018 (1) Consolidated Financial Results 1Q of Fiscal 2018 (2) Results by Business Segment 1Q of Fiscal 2018 (2) Medical Business 1Q of Fiscal 2018 (2) Medical Business (Growth Rates on Local Currency Basis) 1Q of Fiscal 2018 (3) Scientific Solutions Business 1Q of Fiscal 2018 (4) Imaging Business Statement of Financial Position Consolidated Cash Flows Forecast for Fiscal 2018 Forecasts of Consolidated Financial Results for Fiscal 2018 Segment Forecasts for fiscal 2018 Capital Expenditures and R&D Expenditures @ Appendix 【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Results 【Supplementary Materials (JGAAP/IFRS) 】 Segment Results for Fiscal 2017 【Supplementary Materials】 Performance Indicators for FY2017 【Supplementary Materials】 Forecasts for FY2018 (1H and 2H) 【Supplementary Materials】Segment Forecasts for FY2018(1H and 2H) 【Supplementary Materials】 Disclosure of Growth Rates on Local Currency Basis by Medical Business BU Q&A Q&A 1 Q&A 2 Q&A 3 Q&A 4 Q&A 5 Q&A 6 Q&A 7 @ Back Next